Postoperative Residual Curarization
Conditions
Brief summary
This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.
Interventions
DRUGSugammadex
At the end of surgery, neuromucular blockade will be reversed with 2mg/kg or 4mg/kg sugammadex depending on the depth of neuromuscular blockade.
Sponsors
Seoul National University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients undergoing elective surgery under general anesthesia. * American Society of Anesthesiologists grade 1, 2, or 3. * Aged \>18 years
Exclusion criteria
* Refusal to participate in the study * Body Mass Index \< 18.5 kg/m2 or \> 35 kg/m2 * History of neuromuscular disease. * History of allergy to neuromuscular blockade * Scheduled to transfer to the intensive care unit
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative residual neuromuscular blockade | On the arrival of PACU | TOF ratio \< 0.9 |
Countries
South Korea
Contacts
Primary ContactChang-Hoon Koo
Outcome results
None listed